Though male breast cancer is rare, it does occur, and recent FDA guidance urges researchers to include men in clinical trials of breast cancer treatments. Male breast cancer is typically diagnosed at a late stage, most available therapies were not tested in men, and a study published in Annals of Oncology found many men with breast cancer do not receive optimal care.
FDA urges diversity in breast cancer therapy studies
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.